Monthly: Trevi Therapeutics (TRVI: $2.38) rises for a second consecutive month, a two-month rise of 10%

Medicine

Press/Media: Research

PeriodAug 1 2023

Media coverage

1

Media coverage

  • TitleMonthly: Trevi Therapeutics (TRVI: $2.38) rises for a second consecutive month, a two-month rise of 10%
    Media name/outletGlobal Round Up - Bullish & Bearish Signals
    Country/TerritoryUnited States
    Date8/1/23
    PersonsDavid Austin Clark
View all 1
View less